Like all great ideas, the OMS diet concept is beautifully simple. Its key is the nutrient-rich animal feed at the very beginning of the food chain. This also makes the implementation costs minimal, as the properties of extruded linseed are well understood so there is no need for clinical trials.
The results of the project's clinical trials were impressive. Obese volunteers eating a diet comprising meat and dairy products derived from linseed-fed animals lost 3 kg in three months and had sustained the weight loss five months later. Control volunteers who followed alternative types of diet also lost 3 kg, but had regained 1.7 kg five months later.
Market penetration is under way
The results of the trial have been published in the scientific press and Valorex has received official endorsement from the French Government. Valorex OMS meat and dairy products are already being marketed by France's Bleu-Blanc-Coeur Association, a non-profit initiative set up by Valorex and other like-minded animal feed and food manufacturers to promote environmentally responsible farming. Danone, Carrefour and a number of major food manufacturers and retailers are paying premium prices to farmers who use Valorex OMS animal feeds, says Weill.
"EUREKA's support was invaluable in helping us to set up the trials and provide the solid and strong data we needed to convince the French government and retailers. We anticipate that 10% of animal products in France and 2% in Europe as a whole could be derived from OMS-fed animals in the next four years. We are also licensing our patented thermo-extrusion technology, and already have agreements with factories in Germany, Portugal and Switzerland."
Valorex's potential global market for the product is huge. Quite apart from revolutionising the diets of the estimated 300 million overweight people in the world, of whom 75 million people are at risk of developing Metabolic Syndrome, all cons
|Contact: Shar McKenzie|